AGIOS PHARMACEUTICALS INC
AGIONASDAQ🏆 #2001 by market capEarnings Oct 29US Equity
$33.48▲ $0.18 (+0.54%)
LiveTrack AGIO
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▼ 2.0%
14d▲ 1.7%
30d▼ 0.6%
ytd▲ 23.0%
1y▼ 16.7%
🏦Market Cap
$2.00B
Small Cap
📈Revenue Growth (YoY)
+48.0%
High Growth
📊Gross Margin
87.9%
High
💵FCF Margin
-371.4%
Thin
⚖️P/S Ratio
20.2x
Expensive
Otter Score
72
Fair
AGIOS PHARMACEUTICALS INC
AGIOAnalyst Ratings
Price
$33.48
Total
29
Raised
4
Lowered
2
Avg PT
$42.67
H / L
$55 / $32
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
B of A Securities | Reiterated | Buy | 2026-09-21 | — | — |
JP Morgan | Reiterated | Neutral | 2026-08-07 | $33.00 | −1.40% |
Citigroup | Reiterated | Buy | 2026-07-31 | — | — |
Truist Securities | Reiterated | Buy | 2026-07-31 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 | — | — |
RBC Capital | Reiterated | Sector Perform | 2026-07-07 | $32.00 | −4.40% |
Goldman Sachs | Reiterated | Neutral | 2026-04-01 | $25.00 | −25.30% |
Leerink Partners | Reiterated | Outperform | 2025-12-26 | $40.00 | +19.50% |
Scotiabank | Reiterated | Sector Outperform | 2025-07-28 | $71.00 | +112.10% |
Cantor Fitzgerald | Reiterated | Overweight | 2024-12-18 | — | — |
Piper Sandler | Reiterated | Overweight | 2023-02-03 | $41.00 | +22.50% |
SVB Leerink | Reiterated | Outperform | 2022-08-05 | — | — |
Canaccord Genuity | Reiterated | Buy | 2022-02-16 | — | — |
Raymond James | Reiterated | Market Perform → Perform | 2021-07-01 | $51.00 | +52.30% |
Barclays | Upgraded | Equal Weight → Overweight | 2020-10-22 | $70.00 | +109.10% |
Needham | Reiterated | Buy | 2020-10-19 | — | — |
BMO Capital | Reiterated | Outperform | 2019-12-09 | — | — |
Guggenheim | Upgraded | Neutral → Buy | 2019-09-23 | — | — |
Leerink Swann | Upgraded | Market Perform → Outperform | 2019-02-15 | — | — |
PiperJaffray | Reiterated | Overweight | 2018-05-31 | — | — |
Credit Suisse | Reiterated | Outperform | 2018-04-11 | — | — |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2017-06-26 | — | — |
Janney Capital | Downgraded | Buy → Neutral | 2017-06-26 | — | — |
Oppenheimer | Upgraded | Perform → Outperform | 2017-01-17 | — | — |
BTIG Research | Reiterated | Neutral | 2016-08-19 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2016-03-30 | — | — |
Northland Securities | Reiterated | Outperform | 2015-07-22 | — | — |
MLV & Co. | Reiterated | Buy | 2014-12-04 | — | — |
Cowen & Co. | Reiterated | Outperform | 2013-08-19 | — | — |
Institution
B of A Securities
Reiterated · Buy · 2026-09-21
—
—
JP Morgan
Reiterated · Neutral · 2026-08-07
$33.00
−1.40%
Citigroup
Reiterated · Buy · 2026-07-31
—
—
Truist Securities
Reiterated · Buy · 2026-07-31
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-07-30
—
—
RBC Capital
Reiterated · Sector Perform · 2026-07-07
$32.00
−4.40%
Goldman Sachs
Reiterated · Neutral · 2026-04-01
$25.00
−25.30%
Leerink Partners
Reiterated · Outperform · 2025-12-26
$40.00
+19.50%
Scotiabank
Reiterated · Sector Outperform · 2025-07-28
$71.00
+112.10%
Cantor Fitzgerald
Reiterated · Overweight · 2024-12-18
—
—
Piper Sandler
Reiterated · Overweight · 2023-02-03
$41.00
+22.50%
SVB Leerink
Reiterated · Outperform · 2022-08-05
—
—
Canaccord Genuity
Reiterated · Buy · 2022-02-16
—
—
Raymond James
Reiterated · Market Perform → Perform · 2021-07-01
$51.00
+52.30%
Barclays
Upgraded · Equal Weight → Overweight · 2020-10-22
$70.00
+109.10%
Needham
Reiterated · Buy · 2020-10-19
—
—
BMO Capital
Reiterated · Outperform · 2019-12-09
—
—
Guggenheim
Upgraded · Neutral → Buy · 2019-09-23
—
—
Leerink Swann
Upgraded · Market Perform → Outperform · 2019-02-15
—
—
PiperJaffray
Reiterated · Overweight · 2018-05-31
—
—
Credit Suisse
Reiterated · Outperform · 2018-04-11
—
—
Janney Montgomery Scott
Downgraded · Buy → Neutral · 2017-06-26
—
—
Janney Capital
Downgraded · Buy → Neutral · 2017-06-26
—
—
Oppenheimer
Upgraded · Perform → Outperform · 2017-01-17
—
—
BTIG Research
Reiterated · Neutral · 2016-08-19
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2016-03-30
—
—
Northland Securities
Reiterated · Outperform · 2015-07-22
—
—
MLV & Co.
Reiterated · Buy · 2014-12-04
—
—
Cowen & Co.
Reiterated · Outperform · 2013-08-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space